So grateful to have passed the #Cardiology boards and won the Peter Russell Award. Many thanks to everyone who has trained and supported me along the way - the patients, nurses, allied health, attendings, co-fellows, and family. Special thanks to @hvanspall - the best mentor ever
@hvanspall@PHRIresearch@MacDeptMed@LibinInstitute Thank you so much! I have come so far because of you - your mentorship, advocacy, and ability to inspire others to excellence. Looking forward to the next chapter of my training!
Last call shift of #Cardiology fellowship done! Many thanks to the wonderful CCU nurses who have supported and taught me along the way. Special thanks to #Sonosite, the real MVP ❤️
In our validation study, we demonstrate that the simple LE index can predict 30d mortality using only length of stay and # of prior ED visits, with better performance than traditional risk scores. Many thanks to @hvanspall and the team!
You can predict 30d ☠️ following #HF#hospitalization w just 2 variables
- Length of 🏥stay
- n of ED visits in prior 6 mo
In an external validation study (n 1206) our simple #LE index performed better than complex #risk scores
Each point: ~2x odds of☠️
https://t.co/6WKgFO2aie
In our 5 year sex disaggregated analysis of the #PACTHF trial:
🔴 no sex differences in clinical outcomes, total costs
🔴 high event rates - 65% ☠️, 85% 🏥
🔴⬆️ costs from specialist visits in ♂️, ⬆️ costs from supportive care in ♀️
Many thanks to @hvanspall and the whole team!!
In pragmatic #RCT of 4441 ppl post #HF#hospitalization
5y #prognosis‼️
65%☠️
85% 🏥 (avg 3 rehosps pp)
#EventRates highest in yr 1
Annual #cost $80.5 K pp, largely from 🏥s
No sex differences in event rates & total $, but less specialist care in 👩🏼🦳
https://t.co/OMZo11ytyH
#GlobalRounds@CircAHA visits #Canada 🇨🇦 41 million people
Universal healthcare (11% GDP)
High life expectancy : healthcare $
Centrally negotiated drug prices
And opportunities for improvement👇🏽
How does your #healthcare system compare?
@taubenA#KStelkia
https://t.co/X8RnbKCSyD
Our #globalrounds on #CVD care in 🇨🇦 was published in #Circulation
🔑 takeaways:
🔴 universal Healthcare
🔴 high-quality care
🔴 outcomes, wait times comparable to high-income countries
🔴 geography limits delivery of care
🔴 national reporting needed
https://t.co/1adg4ss60E
🎙️NEW #HeartFailure2024#LBCT Discussion 💫Dr @hvanspall & Dr @TaubenA discuss the findings from the PACT-HF trial.
📽️Watch here👉 https://t.co/WWuXjMsA90
📊Clinical outcomes and overall costs following hospitalisation for #HF were similar between male and female patients at 5y, although the distribution of costs differed.
#HFA #CardioTwitter
Incredibly grateful to @hvanspall to present #PACTHF 5yr update at #HeartFailure2024
🔑 findings:
🔴 5 year ☠ = 65% in ♂️ and ♀️ patients
🔴 💲were high, and driven by readmission
🔴 🚫 sex differences in outcomes/costs, but ⬆️ specialist care in ♂️, ⬆️ supportive care in ♀️
How do gender differences impact clinical outcomes and healthcare resource use after #HF hospitalization?
#PACTHF registries #LBCT:
📍 64% mortality, 🧔♂️=👩🦳
📍 Higher costs for 🧔♂️ in specialist and invasive care; more home & long-term care for 👩🦳
#HeartFailure2024@hvanspall